novavax
participate
upcoming
investor
conferences
gaithersburg
globe
newswire
novavax
nasdaq
nvax
late
stage
biotechnology
company
developing
vaccines
serious
infectious
diseases
today
announced
participate
five
upcoming
investor
conferences
topic
discussion
novavax
vaccine
candidate
conference
details
follows
citi
annual
biopharma
virtual
conference
date
september
event
investor
meetings
wainwright
annual
global
investment
conference
date
september
time
eastern
time
et
event
corporate
presentation
investor
meetings
live
webcast
investors
events
cantor
virtual
global
healthcare
conference
date
september
time
eastern
time
et
event
fireside
chat
investor
meetings
live
webcast
investors
events
morgan
stanley
virtual
annual
global
healthcare
conference
date
september
time
eastern
time
et
event
fireside
chat
investor
meetings
live
webcast
investors
events
leerink
cyberrx
series
vaccine
forum
date
september
time
eastern
time
et
event
fireside
chat
replay
presentations
also
accessible
investors
events
section
novavax
novavax
nasdaq
nvax
biotechnology
company
promotes
improved
health
globally
discovery
development
commercialization
innovative
vaccines
prevent
serious
infectious
diseases
novavax
undergoing
clinical
trials
vaccine
candidate
virus
causes
quadrivalent
influenza
nanoparticle
vaccine
met
primary
objectives
pivotal
phase
clinical
trial
older
adults
vaccine
candidates
incorporate
novavax
proprietary
adjuvant
order
enhance
immune
response
stimulate
high
levels
neutralizing
antibodies
novavax
leading
innovator
recombinant
vaccines
proprietary
recombinant
technology
platform
combines
power
speed
genetic
engineering
efficiently
produce
highly
immunogenic
nanoparticles
order
address
urgent
global
health
needs
information
visit
connect
us
twitter
linkedin
investors
silvia
taylor
erika
trahan
ir
